期刊
EUROPEAN NEUROPSYCHOPHARMACOLOGY
卷 25, 期 1, 页码 95-99出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.euroneuro.2014.11.019
关键词
Transgender; Estradiol; Testosterone; Neurotrophin; Gender identity disorder; Gender dysphoria
资金
- Bayer
Serum levels of brain-derived neurotrophic factor (BDNF) are reduced in male-to-female transsexual persons (MtF) compared to male controls. It was hypothesized before that this might reflect either an involvement of BDNF in a biomechanism of transsexualism or to be the result of persistent social stress due to the condition. Here, we demonstrate that 12 month of cross-sex hormone treatment reduces serum BDNF levels in male-to-female transsexual persons independent of anthropometric measures. Participants were acquired through the European Network for the Investigation of Gender Incongruence (ENIGI). Reduced serum BDNF in MtF thus seems to be a result of hormonal treatment rather than a consequence or risk factor of transsexualism. (C) 2014 Elsevier B.V. and ECNP. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据